These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24986096)

  • 1. Effects of sugammadex on coagulation: it does not represent a bleeding risk in surgical patients.
    Carron M
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):824. PubMed ID: 24986096
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
    De Kam PJ; Grobara P; Prohn M; Höppener F; Kluft C; Burggraaf J; Langdon RB; Peeters P
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):227-36. PubMed ID: 24447651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients.
    Rahe-Meyer N; Fennema H; Schulman S; Klimscha W; Przemeck M; Blobner M; Wulf H; Speek M; McCrary Sisk C; Williams-Herman D; Woo T; Szegedi A
    Anesthesiology; 2014 Nov; 121(5):969-77. PubMed ID: 25208233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PK-PD model-based assessment of sugammadex effects on coagulation parameters.
    Bosch R; van Lierop MJ; de Kam PJ; Kruithof AC; Burggraaf J; de Greef R; Visser SA; Johnson-Levonas AO; Kleijn HJ
    Eur J Pharm Sci; 2016 Mar; 84():9-17. PubMed ID: 26747019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters.
    de Kam PJ; El Galta R; Kruithof AC; Fennema H; van Lierop MJ; Mihara K; Burggraaf J; Moerland M; Peeters P; Troyer MD
    Int J Clin Pharmacol Ther; 2013 Dec; 51(12):976-85. PubMed ID: 24120718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant Effect of Sugammadex: Just an In Vitro Artifact.
    Dirkmann D; Britten MW; Pauling H; Weidle J; Volbracht L; Görlinger K; Peters J
    Anesthesiology; 2016 Jun; 124(6):1277-85. PubMed ID: 26950705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects.
    De Kam PJ; Kruithof AC; van Lierop MJ; Moerland M; Dennie J; Troyer MD; Langdon RB; Gutstein DE; Burggraaf J; El Galta R
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):631-41. PubMed ID: 24800921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Sugammadex on Postoperative Bleeding and Coagulation Parameters After Septoplasty: A Randomized Prospective Study.
    Taş N; Korkmaz H; Yağan Ö; Korkmaz M
    Med Sci Monit; 2015 Aug; 21():2382-6. PubMed ID: 26271275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding Risk in Surgical Patients Receiving Sugammadex: Definitive Conclusions Are Not Yet Possible.
    Carron M
    Anesthesiology; 2015 Nov; 123(5):1212. PubMed ID: 26485626
    [No Abstract]   [Full Text] [Related]  

  • 10. Precipitation in Gallipoli: sugammadex / amiodarone & sugammadex / dobutamine & sugammadex / protamine.
    Hancı V; Ali Kiraz H; Ömür D; Ekin S; Uyan B; Yurtlu BS
    Braz J Anesthesiol; 2013; 63(1):163-4. PubMed ID: 23438811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count].
    Scheckenbach K; Bier H; Hoffmann TK; Windfuhr JP; Bas M; Laws HJ; Plettenberg C; Wagenmann M
    HNO; 2008 Mar; 56(3):312-20. PubMed ID: 17581692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo animal studies with sugammadex.
    Booij LH; van Egmond J; Driessen JJ; de Boer HD
    Anaesthesia; 2009 Mar; 64 Suppl 1():38-44. PubMed ID: 19222430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged activated partial thromboplastin time, Quick's time, bleeding time. Diagnostic orientation].
    Guillin MC
    Rev Prat; 1994 Sep; 44(14):1942-8. PubMed ID: 7939287
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnesium sulphate effects on sugammadex reversal time - a reply.
    Germano Filho PA
    Anaesthesia; 2015 Dec; 70(12):1457-8. PubMed ID: 26558864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sugammadex--two years in clinical practice].
    Glinka L; Onichimowski D; Sieniuta P; Korecki A
    Anestezjol Intens Ter; 2010; 42(3):155-9. PubMed ID: 21413422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation.
    Chee YL
    J R Coll Physicians Edinb; 2014; 44(1):42-5. PubMed ID: 24995447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of intrapartum and postpartum bleeding based on changes in blood coagulation and fibrinolysis during pregnancy].
    Fuse Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):405-10. PubMed ID: 3494090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade.
    Abad-Gurumeta A; Ripollés-Melchor J; Casans-Francés R; Espinosa A; Martínez-Hurtado E; Fernández-Pérez C; Ramírez JM; López-Timoneda F; Calvo-Vecino JM;
    Anaesthesia; 2015 Dec; 70(12):1441-52. PubMed ID: 26558858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex - time of onset: nine months.
    Dalton J; Van Hasselt G
    Anaesthesia; 2016 Jan; 71(1):115-6. PubMed ID: 26684534
    [No Abstract]   [Full Text] [Related]  

  • 20. A train-of-four ratio of 0.9 may not certify adequate recovery after sugammadex.
    Suzuki T
    Acta Anaesthesiol Scand; 2011 Mar; 55(3):368-9. PubMed ID: 21288221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.